Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR)

Currency in TRY
35.00
-1.10(-3.05%)
Closed·
MEDTR Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
MEDTR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
35.0036.16
52 wk Range
25.5255.00
Key Statistics
Bid/Ask
35.00 / 35.10
Prev. Close
36.1
Open
36.12
Day's Range
35-36.16
52 wk Range
25.52-55
Volume
624.61K
Average Volume (3m)
857.31K
1-Year Change
-14.63%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MEDTR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
68.90
Upside
+96.86%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Meditera Tibbi Malzeme Sanayi ve Ticaret AS Company Profile

Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi manufactures and sells medical devices in Turkey. The company offers breathing sytems products, including breathing circuits, breathing filters, catheter mounts, gas sampling lines, accessories, masks, and connectors. It also provides hospital products, such as barrier cream, surgical hand brushes for skin disinfection, hand and skin antiseptics, and skin and mucosa antiseptics. In addition, the company engages in the manufacturing and sale of anesthesia and intensive care circuits; installation, operation, and design of oncology drug preparation and delivery systems; production, sales, and technical service of infusion pumps and sets; and manufacturing of biocidal products. It also exports its products to 80 countries under its Altech brand name. Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi was founded in 1983 and is headquartered in Izmir, Turkey.

Compare MEDTR to Peers and Sector

Metrics to compare
MEDTR
Peers
Sector
Relationship
P/E Ratio
−371.6x−11.4x−0.5x
PEG Ratio
3.26−0.340.00
Price/Book
1.7x3.3x2.6x
Price / LTM Sales
2.0x4.5x3.3x
Upside (Analyst Target)
96.9%72.0%43.5%
Fair Value Upside
Unlock6.5%6.8%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 68.90
(+96.86% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.09%
Dividend Yield
0.72%
Industry Median 0.79%
Annualised payout
0.25
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 09, 2025
EPS / Forecast
-0.59 / --
Revenue / Forecast
600.00M / --
EPS Revisions
Last 90 days

MEDTR Income Statement

People Also Watch

164.00
TUPRS
-0.18%
41.22
MAVI
-0.77%
117.50
ULKER
+1.29%
263.750
PGSUS
+0.76%
106.70
ASTOR
+2.50%

FAQ

What Stock Exchange Does Meditera Tibbi Malzeme Sanayi ve Ticaret AS Trade On?

Meditera Tibbi Malzeme Sanayi ve Ticaret AS is listed and trades on the Istanbul Stock Exchange stock exchange.

What Is the Stock Symbol for Meditera Tibbi Malzeme Sanayi ve Ticaret AS?

The stock symbol for Meditera Tibbi Malzeme Sanayi ve Ticaret AS is "MEDTR."

What Is the Meditera Tibbi Malzeme Sanayi ve Ticaret AS Market Cap?

As of today, Meditera Tibbi Malzeme Sanayi ve Ticaret AS market cap is 4.17B.

What Is Meditera Tibbi Malzeme Sanayi ve Ticaret AS's Earnings Per Share (TTM)?

The Meditera Tibbi Malzeme Sanayi ve Ticaret AS EPS (TTM) is -0.09.

When Is the Next Meditera Tibbi Malzeme Sanayi ve Ticaret AS Earnings Date?

Meditera Tibbi Malzeme Sanayi ve Ticaret AS will release its next earnings report on 05 Nov 2025.

From a Technical Analysis Perspective, Is MEDTR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Meditera Tibbi Malzeme Sanayi ve Ticaret AS Stock Split?

Meditera Tibbi Malzeme Sanayi ve Ticaret AS has split 1 times.

How Many Employees Does Meditera Tibbi Malzeme Sanayi ve Ticaret AS Have?

Meditera Tibbi Malzeme Sanayi ve Ticaret AS has 806 employees.

What is the current trading status of Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR)?

As of 09 Aug 2025, Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) is trading at a price of 35.00, with a previous close of 36.10. The stock has fluctuated within a day range of 35.00 to 36.16, while its 52-week range spans from 25.52 to 55.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.